GENOTYPIC RESISTANCE PROFILE OF HIV-1 PROTEASE GENE: A PRELIMINARY REPORT FROM VELLORE, SOUTH INDIA

被引:0
|
作者
Kandathil, A. J. [1 ]
Kannangai, R. [1 ]
Abraham, O. C. [2 ]
Sudarsanam, T. D. [2 ]
Pulimood, S. A. [3 ]
Sridharan, G. [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Clin Virol, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept Internal Med, Vellore 632004, Tamil Nadu, India
[3] Christian Med Coll & Hosp, Dept Dermatol, Vellore 632004, Tamil Nadu, India
关键词
Drug resistance; India; HIV-1; protease gene mutations;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 subtypes other than B are responsible for most new HIV infections worldwide; virus sequence data for drug resistance is described only from a limited number of non-B subtype HIV-1. This study is on mutations and polymorphisms of HIV-1 protease gene that can predict drug resistance in subtype C. The genotypic resistance assay was carried out on 38 HIV-1 strains with their plasma RNA and in nine, the proviral protease gene was sequenced. The treatment nave strains showed minor resistance mutations, there were no major resistance mutations in the protease gene. We suggest the use of resistance testing to monitor individuals on therapy and also before initiation of therapy, gathering more sequence information for a data bank of Indian strains.
引用
收藏
页码:151 / 154
页数:4
相关论文
共 50 条
  • [1] Prevalence of drug resistance mutations in HIV-1 protease gene from North India
    Mohd Azam
    Abida Malik
    Meher Rizvi
    Supriya Singh
    Hanu Ram
    Megha Singhal
    Poonam Gupta
    BMC Infectious Diseases, 12 (Suppl 1)
  • [2] Resilience to resistance of HIV-1 protease inhibitors: Profile of darunavir
    Lefebvre, Eric
    Schiffer, Celia A.
    AIDS REVIEWS, 2008, 10 (03) : 131 - 142
  • [3] HIV-1 genotypic and phenotypic resistance
    Hanna, GJ
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (03) : 637 - +
  • [4] The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors
    Martinez-Cajas, Jorge L.
    Wainberg, Mark A.
    Oliveira, Maureen
    Asahchop, Eugene L.
    Doualla-Bell, Florence
    Lisovsky, Irene
    Moisi, Daniela
    Mendelson, Ella
    Grossman, Zehava
    Brenner, Bluma G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 988 - 994
  • [5] Mutant HIV-1 protease complexed with tetrapeptide inhibitor -: Preliminary report
    Skálová, T
    Hasek, J
    Dohnálek, J
    Petroková, H
    Buchtelová, E
    ACTA PHYSICA POLONICA A, 2002, 101 (05) : 659 - 663
  • [6] Resistance to HIV-1 protease inhibitors
    Swanstrom, R
    Smith, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 58 - BIOT
  • [7] HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Parana Brazil
    Michelon Toledo, Paula Virginia
    de Carvalho, Denise Siqueira
    Romagnoli, Luiza
    Marcinko, Gustavo
    da Cunha, Clovis Arns
    de Souza, Margely Nunes
    Brindeiro, Rodrigo
    de Queiroz-Telles, Flavio
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (04): : 360 - 371
  • [8] Improved prediction of HIV-1 protease genotypic resistance testing assays using a consensus technique
    Thomas, Alex C.
    Yang, Zheng Rong
    2006 IEEE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORK PROCEEDINGS, VOLS 1-10, 2006, : 2308 - +
  • [9] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [10] Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data:: the role of secondary mutations
    Servais, J
    Plesséria, JM
    Lambert, C
    Fontaine, E
    Robert, I
    Arendt, V
    Staub, T
    Schneider, F
    Hemmer, R
    Schmit, JC
    ANTIVIRAL THERAPY, 2001, 6 (04) : 239 - 248